MSB 0.66% $1.53 mesoblast limited

Alzheimer drug approved, page-34

  1. 15,756 Posts.
    lightbulb Created with Sketch. 5768
    This is another piece of interesting information in the article .... no point rushing the confirmatory trial I guess if you know it lacks efficacy ? 9 years to complete the confirmatory trial - what a joke ?

    https://www.abc.net.au/news/2021-06-08/us-approves-first-alzheimers-drug-in-20-years/100197170

    The company said it aims to complete its follow-up trial of the drug by 2030.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.53
Change
0.010(0.66%)
Mkt cap ! $1.712B
Open High Low Value Volume
$1.50 $1.54 $1.48 $5.605M 3.713M

Buyers (Bids)

No. Vol. Price($)
5 55197 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.53 29782 3
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.